Yoshinaga Ito

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis”.

Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis

Cell(2021)10.1016/j.cell.2021.01.022

N/A

0.897DataRank · unranked

394 citations

Orr Ashenberg, Itay Tirosh, Simon Gritsch, Elizabeth M. Perez, Sascha Marx +38 more

Rapid CLIP dissociation from MHC II promotes an unusual antigen presentation pathway in autoimmunity

Journal of Experimental Medicine(2018)10.1084/jem.20180300

N/A

0.470DataRank · unranked

22 citations

Orr Ashenberg, Jason Pyrdol, Adrienne M. Luoma, Matan Hofree, Elena Christian +10 more

Inhibition of MICA and MICB Shedding Elicits NK-Cell–Mediated Immunity against Tumors Resistant to Cytotoxic T Cells

Cancer Immunology Research(2020)10.1158/2326-6066.cir-19-0483

N/A

0DataRank · unranked

120 citations

Sushil Kumar, Adrienne Luoma, Yoshinaga Ito, Pedro Henrique Alves da Silva, Deng Pan +4 more

Hdac3 is an epigenetic inhibitor of the cytotoxicity program in CD8 T cells

The Journal of Experimental Medicine(2020)10.1084/jem.20191453

N/A

0DataRank · unranked

69 citations

Olamide Olawoyin, Paloma Cejas, Yingtian Xie, Clifford A. Meyer, Yoshinaga Ito +7 more

CARM1 Inhibition Enables Immunotherapy of Resistant Tumors by Dual Action on Tumor Cells and T Cells

Cancer Discovery(2021)10.1158/2159-8290.cd-20-1144

N/A

0DataRank · unranked

98 citations

Zexian Zeng, Archis Bagati, Rong En Tay, Lionel A. Sanz, Stella R. Hartono +17 more

Addressing Tumor Heterogeneity by Sensitizing Resistant Cancer Cells to T cell–Secreted Cytokines

Cancer Discovery(2023)10.1158/2159-8290.cd-22-1125

N/A

0DataRank · unranked

21 citations

Deng Pan, Wubing Zhang, Xixi Zhang, Tiffany Y. Juan, Jason W. Pyrdol +5 more

Data from CARM1 Inhibition Enables Immunotherapy of Resistant Tumors by Dual Action on Tumor Cells and T Cells

(2023)10.1158/2159-8290.c.6549178.v1

N/A

0DataRank · unranked

0 citations

Zexian Zeng, Archis Bagati, Rong En Tay, Lionel A. Sanz, Stella R. Hartono +17 more

Defective removal of invariant chain peptides from MHC class II suppresses tumor antigen presentation and promotes tumor growth

Cell Reports(2025)10.1016/j.celrep.2024.115150

N/A

0DataRank · unranked

9 citations

Yoshinaga Ito, Kai W. Wucherpfennig, Paul A. Roche, Joanna Bandola-Simon